Email bulletins


January 2019

  • Lancet Commission recommends actions to support elimination of hepatitis C
  • HCV modelling study
  • HIV/HCV co-infection and end-stage liver disease
  • Survival after liver cancer diagnosis is shorter in people living with HIV
  • Conditional cash transfers to encourage hepatitis C diagnosis and treatment in people who inject drugs
  • Barriers to HCV treatment in people who inject drugs
  • TAF for hepatitis B
  • AbbVie legal challenge in UK tender exercise dismissed
  • Is this your copy of the infohep news bulletin?